S.21/E.17

In this week’s episode, “Cancer Care in Transition: Precision Medicine, Immunotherapy, and Patient Choice,” we look at how cancer treatment is changing at the exact moment when patients are trying to move from crisis mode into something like a new normal. Precision medicine now uses a person’s genes, tumor markers, and even lifestyle to match them with targeted drugs or immunotherapies instead of one‑size‑fits‑all chemo, while immuno‑oncology has created a growing group of survivors living with long‑term effects and unique follow‑up needs. At the same time, shared decision‑making has become essential: patients are being asked to weigh complex options with different risks, benefits, costs, and impacts on quality of life—and their preferences, values, and tolerance for uncertainty can dramatically shape which path is “right” for them.

 

 

We’ll talk about what this transition looks like in real life, how precision tools and immunotherapy are reshaping survivorship, and how patients and caregivers can find their voice when the choices are anything but simple.